Surviving the Valley: Lessons from the moments that look like failure but isn’t

Biotech is a field where progress is nonlinear, the stakes are immense, and “failure” is often just another word for iteration. In this interview, a leading biotech builder reflects on what it really means to survive the valley, the stretches where data disappoints, financing tightens, timelines slip, or the path forward becomes unclear.